Variant report
Variant | nsv971999 |
---|---|
Chromosome Location | chr11:33210606-33212073 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:61)
- Chromatin interactive region (count:1)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CREB1 | chr11:33211570-33211750 | A549 | lung: | n/a | n/a |
2 | MAX | chr11:33211708-33212027 | K562 | blood: | n/a | n/a |
3 | MYC | chr11:33210668-33210767 | HUVEC | blood vessel: | n/a | n/a |
4 | POLR2A | chr11:33211904-33212225 | ProgFib | skin: | n/a | n/a |
5 | POLR2A | chr11:33211619-33211754 | MCF-7 | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:33211414-33211464 | HRCEpiC | kidney: | n/a |
2 | chr11:33211414-33211464 | AG10803 | skin: | n/a |
3 | chr11:33211414-33211464 | HEEpiC | esophagus: | n/a |
4 | chr11:33211414-33211464 | U87 | brain: | n/a |
5 | chr11:33211414-33211464 | ovcar-3 | ovarian: | n/a |
6 | chr11:33211414-33211464 | HMEC | breast: | n/a |
7 | chr11:33211414-33211464 | HUVEC | blood vessel: | n/a |
8 | chr11:33211414-33211464 | HPAEpiC | pulmonary alveolar: | n/a |
9 | chr11:33211414-33211464 | Caco-2 | colon: | n/a |
10 | chr11:33211414-33211464 | A549 | lung: | n/a |
11 | chr11:33211414-33211464 | HCF | heart: | n/a |
12 | chr11:33211414-33211464 | RPTEC | kidney: | n/a |
13 | chr11:33211414-33211464 | SAEC | small airway: | n/a |
14 | chr11:33211414-33211464 | GM12891 | blood: | n/a |
15 | chr11:33211414-33211464 | NHBE | bronchial: | n/a |
16 | chr11:33211414-33211464 | HIPEpiC | eye: | n/a |
17 | chr11:33211414-33211464 | NB4 | blood: | n/a |
18 | chr11:33211414-33211464 | IMR90 | lung: | fetal |
19 | chr11:33211414-33211464 | MCF10A-Er-Src | breast: | n/a |
20 | chr11:33211414-33211464 | HCT-116 | colon: | n/a |
21 | chr11:33211414-33211464 | SK-N-MC | brain: | n/a |
22 | chr11:33211414-33211464 | BJ | skin: | n/a |
23 | chr11:33211414-33211464 | H1-hESC | embryonic stem cell: | embryo |
24 | chr11:33211414-33211464 | PANC-1 | pancreas: | n/a |
25 | chr11:33211414-33211464 | PFSK-1 | brain: | n/a |
26 | chr11:33211414-33211464 | NHDF-neo | bronchial: | n/a |
27 | chr11:33211414-33211464 | HCM | heart: | n/a |
28 | chr11:33211414-33211464 | GM19239 | blood: | n/a |
29 | chr11:33211414-33211464 | AG09309 | skin: | n/a |
30 | chr11:33211414-33211464 | HCPEpiC | choroid plexus: | n/a |
31 | chr11:33211414-33211464 | SK-N-SH | brain: | n/a |
32 | chr11:33211414-33211464 | AG09319 | gingival: | n/a |
33 | chr11:33211414-33211464 | GM12892 | blood: | n/a |
34 | chr11:33211414-33211464 | GM06990 | blood: | n/a |
35 | chr11:33211414-33211464 | HRPEpiC | eye: | n/a |
36 | chr11:33211414-33211464 | HNPCEpiC | eye: | n/a |
37 | chr11:33211414-33211464 | NH-A | brain: | n/a |
38 | chr11:33211414-33211464 | SKMC | muscle: | n/a |
39 | chr11:33211414-33211464 | Hepatocyte | liver: | n/a |
40 | chr11:33211414-33211464 | ProgFib | skin: | n/a |
41 | chr11:33211414-33211464 | Jurkat | blood: | n/a |
42 | chr11:33211414-33211464 | HEK293 | kidney: | embryo |
43 | chr11:33211414-33211464 | AG04449 | skin: | fetal |
44 | chr11:33211414-33211464 | BE2_C | brain: | n/a |
45 | chr11:33211414-33211464 | HepG2 | liver: | n/a |
46 | chr11:33211414-33211464 | ECC-1 | luminal epithelium: | n/a |
47 | chr11:33211414-33211464 | Hela-S3 | cervix: | n/a |
48 | chr11:33211414-33211464 | PrEC | prostate: | n/a |
49 | chr11:33211414-33211464 | HL-60 | blood: | n/a |
50 | chr11:33211414-33211464 | AG04450 | lung: | fetal |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:33209345..33211297-chr11:33213358..33214880,2 | K562 | blood: |
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CSTF3-3 | chr11:33211608-33212049 | NONHSAT018693 |
2 | lnc-TCP11L1-1 | chr11:33210914-33211103 | NONHSAT018691 |
3 | lnc-TCP11L1-1 | chr11:33211479-33211840 | ENSG00000247151 |
4 | lnc-TCP11L1-1 | chr11:33211479-33213142 | NONHSAT018691 |
5 | lnc-TCP11L1-1 | chr11:33210914-33211103 | ENSG00000247151 |
6 | lnc-TCP11L1-1 | chr11:33211479-33213144 | ENSG00000247151 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL29P23 | TF binding region |
RPL29P23 | CpG island |
PSME3 | miRNA target sites |
ARID2 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187435405 | chr11:33210634-33210635 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576874667 | chr11:33210643-33210644 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559209626 | chr11:33210651-33210652 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544024057 | chr11:33210661-33210662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528400257 | chr11:33210686-33210687 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371303281 | chr11:33210687-33210688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs111886177 | chr11:33210733-33210734 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553428368 | chr11:33210777-33210778 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143626152 | chr11:33210814-33210815 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs527756483 | chr11:33210855-33210856 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376821790 | chr11:33210862-33210863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537111342 | chr11:33210870-33210871 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551058674 | chr11:33210951-33210952 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs191567331 | chr11:33210967-33210968 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs183996102 | chr11:33211007-33211008 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs553430510 | chr11:33211009-33211010 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs572354703 | chr11:33211015-33211016 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs536168347 | chr11:33211065-33211066 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs555637860 | chr11:33211087-33211088 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs34288893 | chr11:33211103-33211104 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs575796172 | chr11:33211114-33211115 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544523343 | chr11:33211158-33211159 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs11602835 | chr11:33211164-33211165 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs11032198 | chr11:33211190-33211191 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs147193155 | chr11:33211238-33211239 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139599746 | chr11:33211256-33211257 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528336441 | chr11:33211367-33211368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541732287 | chr11:33211373-33211374 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73482881 | chr11:33211376-33211377 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs375595089 | chr11:33211415-33211416 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs560113810 | chr11:33211460-33211461 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs35575903 | chr11:33211479-33211480 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs550535105 | chr11:33211497-33211498 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs149749101 | chr11:33211498-33211499 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs144217230 | chr11:33211502-33211503 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs560300239 | chr11:33211534-33211535 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs565184296 | chr11:33211573-33211574 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs566879199 | chr11:33211602-33211603 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs148710763 | chr11:33211622-33211623 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs556021362 | chr11:33211639-33211640 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs187459195 | chr11:33211695-33211696 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs538421107 | chr11:33211737-33211738 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs192687847 | chr11:33211738-33211739 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs72908730 | chr11:33211791-33211792 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs545508939 | chr11:33211921-33211922 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs7929507 | chr11:33211922-33211923 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs572509097 | chr11:33211930-33211931 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs143635551 | chr11:33211985-33211986 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs184533021 | chr11:33212016-33212017 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs530741106 | chr11:33212026-33212027 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21364760 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Aniridia syndrome | 21572526 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Denys-drash syndrome | 21085971 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
WAGR syndrome | 16773131 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Aniridia syndrome | 17204608 | CNVD |
Mental retardation | 17204608 | CNVD |
WAGR syndrome | 19617690 | CNVD |
genitourinary abnormalities | 17204608 | CNVD |
Breast cancer | 16397240 | CNVD |
Mental retardation | 16773131 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17160897 | CNVD |
Cancer | 21183584 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
WAGR syndrome | 22470819 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Denys-drash syndrome | 19566914 | CNVD |
Familial wilms tumor | 19566914 | CNVD |
Frasier syndrome | 19566914 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
WAGR syndrome | 20603712 | CNVD |
Autism | 17322880 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21858162 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 16620391 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:33201600-33213400 | Weak transcription | Primary hematopoietic stem cells | blood |
2 | chr11:33202000-33211400 | Weak transcription | Dnd41 | blood |
3 | chr11:33206800-33211400 | Weak transcription | Fetal Muscle Trunk | muscle |
4 | chr11:33208000-33211000 | Enhancers | Fetal Muscle Leg | muscle |
5 | chr11:33209600-33210800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr11:33209600-33218000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr11:33210000-33217000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr11:33210000-33217000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr11:33210400-33212800 | Weak transcription | HSMMtube | muscle |
10 | chr11:33210400-33219800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
11 | chr11:33210600-33212800 | Weak transcription | Fetal Intestine Small | intestine |
12 | chr11:33210600-33214200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
13 | chr11:33210600-33214400 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
14 | chr11:33210800-33219800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr11:33211000-33211600 | Weak transcription | Fetal Muscle Leg | muscle |
16 | chr11:33211400-33211600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
17 | chr11:33211400-33211800 | Enhancers | Fetal Muscle Trunk | muscle |
18 | chr11:33211400-33212000 | Strong transcription | Dnd41 | blood |
19 | chr11:33211600-33211800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr11:33211600-33211800 | Enhancers | Fetal Muscle Leg | muscle |
21 | chr11:33211600-33212800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
22 | chr11:33211800-33214200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
23 | chr11:33211800-33216400 | Weak transcription | Fetal Muscle Trunk | muscle |
24 | chr11:33211800-33216400 | Weak transcription | Fetal Muscle Leg | muscle |
25 | chr11:33212000-33216200 | Weak transcription | Dnd41 | blood |